Blar i Brage NMBU på forfatter "Joranger, Pål"
-
A health economic evaluation of screening and treatment in patients with adolescent idiopathic scoliosis
Adobor, Raphael Dziwornu; Joranger, Pål; Steen, Harald; Navrud, Ståle; Brox, Jens Ivar (Journal article; Peer reviewed, 2014) -
Dog assisted activities, as a group activity : a measure for increased engagement among residents in nursing homes
Sælid, Turid (Master thesis, 2021)Bakgrunn Mangelen på meningsfulle aktiviteter og sosiale og kulturelle opplevelser er et stort problem for mange beboere på norske sykehjem. Ikke sjelden fører det med seg ensomhet, inaktivitet, depresjon, apati eller ... -
Health economic evaluations of shoulder pain, colorectal cancer and scoliosis
Joranger, Pål (PhD Thesis;2015:16, Doctoral thesis, 2018-04-25)Key conclusions In Paper I, a cost-of-illness (COI) study on shoulder pain in Sweden, showed that the mean health care cost per patient was €326 during 6 months, and physiotherapy treatments accounted for 60% of this cost. ... -
Modeling and validating the cost and clinical pathway of colorectal cancer
Joranger, Pål; Nesbakken, Arild; Hoff, Geir; Sorbye, Halfdan; Oshaug, Arne; Aas, Eline (Journal article; Peer reviewed, 2015) -
Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
Borgen, Iren; Garnweidner-Holme, Lisa; Flem Jacobsen, Anne; Bjerkan, Kirsti; Fayyad, Seraj; Joranger, Pål; Lilleengen, Anne Marie; Mosdøl, Annhild; Noll, Josef; Småstuen, Milada Cvancarova; Terragni, Laura; Torheim, Liv Elin; Lukasse, Mirjam (Journal article; Peer reviewed, 2017) -
Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach
Joranger, Pål; Nesbakken, Arild; Sorbye, Halfdan; Hoff, Geir; Oshaug, Arne; Aas, Eline (Peer reviewed; Journal article, 2019)New and emerging advances in colorectal cancer (CRC) treatment combined with limited healthcare resources highlight the need for detailed decision-analytic models to evaluate costs, survival and quality-adjusted life years. ...